CIBLAGE DU FACTEUR TISSULAIRE AUX PLAQUETTES ACTIVÉES

• 收藏
• 分享

专利权人:

Novo Nordisk A/S

发明人:

申请号：

EP17150751.0

公开号：

EP3219723A1

申请日:

2010.08.26

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The current invention relates to procoagulant fusion proteins, polynucleotides that encode said fusion proteins and cells that expresses said fusion proteins. Furthermore, the current invention relates to fusion proteins for use as a medicament. Individuals that have a coagulopathy, such as haemophilia A and B with or without inhibitors, may be treated with fusions proteins of the current invention.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/